Klaudyna Fidyt

Klaudyna Fidyt is a specialized biotechnology research entity based in Wroclaw, Poland, centered on the scientific expertise of Dr. Klaudyna Fidyt. The entity focuses on advanced research in cancer immunology, specifically the development and optimization of Chimeric Antigen Receptor (CAR) T-cell therapies. Dr. Fidyt's work is notably concentrated on addressing T-cell acute lymphoblastic leukemia (T-ALL) through the targeting of CD7. The business operates as a research and development consultancy, contributing to the broader life sciences ecosystem through high-level scientific validation and experimental design. It provides specialized services in the field of natural sciences and engineering, often collaborating with academic and industrial partners in the Polish biotech sector.